MEDINA is a cutting-edge research organization dedicated to natural product-based drug discovery, with a sharp focus on cancer, neurodegenerative disorders, and infectious diseases. Backed by a strong track record of delivering novel drug candidates, we bridge academic innovation with pharmaceutical development. Our multidisciplinary team brings deep industry expertise in project management and small molecule discovery, with specialized capabilities in: • Natural products chemistry & microbiology • High-throughput screening (HTS) • Cell biology • Biomarker discovery & metabolomic profiling • Early ADME and safety profiling At the forefront of innovation, MEDINA has developed a proprietary 3D HTS platform that integrates high-content imaging and AI to identify compounds with antitumor activity. This platform not only detects active compounds but also classifies their mechanisms of action using brightfield imaging and cell painting technologies.